- Home
- WSBC vs VKTX Comparison
WSBC vs VKTX Comparison
Compare WSBC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WSBC | VKTX |
|---|---|---|
| Founded | 1870 | 2012 |
| Country | United States | United States |
| Employees | 2969 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | WSBC | VKTX |
|---|---|---|
| Price | $34.12 | $29.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $39.25 | ★ $95.86 |
| AVG Volume (30 Days) | 611.6K | ★ 2.2M |
| Earning Date | 04-21-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.48% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.31 | N/A |
| Revenue Next Year | $7.06 | N/A |
| P/E Ratio | $16.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.18 | $22.96 |
| 52 Week High | $38.10 | $43.15 |
Technical Indicators
Market Signals| Indicator | WSBC | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.76 | 38.90 |
| Support Level | $32.98 | $23.08 |
| Resistance Level | $34.11 | $35.94 |
| Average True Range (ATR) | 0.63 | 1.45 |
| MACD | -0.01 | -0.26 |
| Stochastic Oscillator | 63.21 | 26.72 |
Price Performance
Historical ComparisonAbout WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.